中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2012年
12期
1765-1766
,共2页
刘玮%陈晋文%李华军%杜文津%陈大伟%靳雁斌
劉瑋%陳晉文%李華軍%杜文津%陳大偉%靳雁斌
류위%진진문%리화군%두문진%진대위%근안빈
脑梗塞%颈动脉疾病%阿托伐他汀%预后
腦梗塞%頸動脈疾病%阿託伐他汀%預後
뇌경새%경동맥질병%아탁벌타정%예후
Brain infarction%Carotid artery diseases%Atorvastatin%Prognosis
目的 探讨阿托伐他汀对老年卒中患者动脉粥样硬化斑块及预后的影响.方法 124例脑卒中患者随机分为两组,观察组64例在常规治疗基础上加用阿托伐他汀20 mg,对照组60例给予常规基础治疗.比较两组治疗后卒中复发率,血脂水平及治疗后患者生活能力情况.结果 (1)治疗组复发率为4.7%,对照组为18.3%(x2=5.76,P<0.05).两组不良反应发生率差异无统计学意义(x2=0.00,P>0.05).(2)治疗组治疗后与治疗前比较,治疗组治疗后与对照组治疗后比较,总胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白-胆固醇(LDL-C)及高密度脂蛋白-胆固醇(HDL-C)水平比较差异均有统计学意义(均P<0.05).(3)治疗后治疗组生活能力显著好于对照组(x2 =24.18,P<0.05).结论 单独应用阿伐他汀能够有效降低缺血性脑卒中患者的血脂水平,改善患者预后、提高患者生活能力及降低卒中发生率,且安全性好.
目的 探討阿託伐他汀對老年卒中患者動脈粥樣硬化斑塊及預後的影響.方法 124例腦卒中患者隨機分為兩組,觀察組64例在常規治療基礎上加用阿託伐他汀20 mg,對照組60例給予常規基礎治療.比較兩組治療後卒中複髮率,血脂水平及治療後患者生活能力情況.結果 (1)治療組複髮率為4.7%,對照組為18.3%(x2=5.76,P<0.05).兩組不良反應髮生率差異無統計學意義(x2=0.00,P>0.05).(2)治療組治療後與治療前比較,治療組治療後與對照組治療後比較,總膽固醇(TC)、三酰甘油(TG)、低密度脂蛋白-膽固醇(LDL-C)及高密度脂蛋白-膽固醇(HDL-C)水平比較差異均有統計學意義(均P<0.05).(3)治療後治療組生活能力顯著好于對照組(x2 =24.18,P<0.05).結論 單獨應用阿伐他汀能夠有效降低缺血性腦卒中患者的血脂水平,改善患者預後、提高患者生活能力及降低卒中髮生率,且安全性好.
목적 탐토아탁벌타정대노년졸중환자동맥죽양경화반괴급예후적영향.방법 124례뇌졸중환자수궤분위량조,관찰조64례재상규치료기출상가용아탁벌타정20 mg,대조조60례급여상규기출치료.비교량조치료후졸중복발솔,혈지수평급치료후환자생활능력정황.결과 (1)치료조복발솔위4.7%,대조조위18.3%(x2=5.76,P<0.05).량조불량반응발생솔차이무통계학의의(x2=0.00,P>0.05).(2)치료조치료후여치료전비교,치료조치료후여대조조치료후비교,총담고순(TC)、삼선감유(TG)、저밀도지단백-담고순(LDL-C)급고밀도지단백-담고순(HDL-C)수평비교차이균유통계학의의(균P<0.05).(3)치료후치료조생활능력현저호우대조조(x2 =24.18,P<0.05).결론 단독응용아벌타정능구유효강저결혈성뇌졸중환자적혈지수평,개선환자예후、제고환자생활능력급강저졸중발생솔,차안전성호.
Objective To explore the influence of atorvastatin on the carotid atherosclerotic plaque and prognosis of older apoplexy.Methods 124 patients with carotid atherosclerotic plaque were randomly divided into 2groups,64 cases in the observetion group who had given atorvastatin(20mg) and general,and 60 cases in control group who had given genenal treatment.The relapse rate of apoplexy,the level of blood-fat and live viability condition were compared.Results ( 1 ) In the treatment group,the recurrence rate was 4.7%,and 18.3 % in the control group,the difference was statistically significant(x2=5.76,P < 0.05 ).The two groups of adverse events had no significant difference ( x2=0.00,P > 0.05 ).(2) In the treatment group,after treatment compared with before treatment,after the treatment group compared with the control group after treatment,TC,TG,LDL-C,HDL-C levels were statistically different ( all P < 0.05 ).(3) The life skills of the treatment group after treatment was signiflcantly better than the control group,the difference was statistically significant( x2 =24.18,P < 0.05 ).Conclusion A torvastatin could significantly reduce the level of blood fat,improve prognosis,and reduce the rate of apoplexy,and had good effect.